These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34804973)

  • 1. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer.
    Yu J; He Z; He X; Luo Z; Lian L; Wu B; Lan P; Chen H
    Front Oncol; 2021; 11():771099. PubMed ID: 34804973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
    Cheng T; Chen P; Chen J; Deng Y; Huang C
    Front Genet; 2021; 12():809600. PubMed ID: 35069702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
    Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
    J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
    Gobin E; Bagwell K; Wagner J; Mysona D; Sandirasegarane S; Smith N; Bai S; Sharma A; Schleifer R; She JX
    BMC Cancer; 2019 Jun; 19(1):581. PubMed ID: 31200666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma.
    Wang T; Zhang Y; Bai J; Xue Y; Peng Q
    BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer.
    Luan H; Jian L; Huang Y; Guo Y; Zhou L
    Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of matrix metalloproteinases and their inhibitors in head and neck squamous cell carcinoma.
    Zou M; Zhang C; Sun Y; Wu H; Xiao F; Gao W; Zhao F; Fan X; Wu G
    Acta Oncol; 2022 Apr; 61(4):505-515. PubMed ID: 34879791
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms.
    Jackson V; Olsson T; Kurtovic S; Folkersen L; Paloschi V; Wågsäter D; Franco-Cereceda A; Eriksson P
    J Thorac Cardiovasc Surg; 2012 Aug; 144(2):459-66. PubMed ID: 21955474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma.
    Xie J; Zhou X; Wang R; Zhao J; Tang J; Zhang Q; Du Y; Pang Y
    Medicine (Baltimore); 2021 Jun; 100(23):e26135. PubMed ID: 34114996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.
    Delassus GS; Cho H; Eliceiri GL
    J Cell Physiol; 2011 Dec; 226(12):3378-84. PubMed ID: 21344390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis.
    Zhang Y; Wang J; Fan Y; Lang F; Fu F; Liu Q
    Clin Transl Oncol; 2024 Mar; 26(3):653-663. PubMed ID: 37523078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP14 predicts a poor prognosis in patients with colorectal cancer.
    Cui G; Cai F; Ding Z; Gao L
    Hum Pathol; 2019 Jan; 83():36-42. PubMed ID: 30120968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma.
    Xu L; Yang H; Yan M; Li W
    Clin Exp Med; 2023 Oct; 23(6):2065-2083. PubMed ID: 36169759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
    Chen Z; Wu G; Ye F; Chen G; Fan Q; Dong H; Zhu X; Wu C
    BMC Cancer; 2019 May; 19(1):448. PubMed ID: 31088409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer.
    Shen C; Da L; Wu Z; Wang Y; Gao S; Tian D; Hu H
    Comb Chem High Throughput Screen; 2021; 24(8):1183-1196. PubMed ID: 32940175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
    Woo M; Park K; Nam J; Kim JC
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase expression and molecular interaction network analysis in gastric cancer.
    Xu J; E C; Yao Y; Ren S; Wang G; Jin H
    Oncol Lett; 2016 Oct; 12(4):2403-2408. PubMed ID: 27698806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and Its Relation to Epigenomic Subtypes and HER2 Overexpression.
    Simonova OA; Kuznetsova EB; Tanas AS; Rudenko VV; Poddubskaya EV; Kekeeva TV; Trotsenko ID; Larin SS; Kutsev SI; Zaletaev DV; Nemtsova MV; Strelnikov VV
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32397602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasion and MMP expression profile in desmoid tumours.
    Denys H; De Wever O; Nusgens B; Kong Y; Sciot R; Le AT; Van Dam K; Jadidizadeh A; Tejpar S; Mareel M; Alman B; Cassiman JJ
    Br J Cancer; 2004 Apr; 90(7):1443-9. PubMed ID: 15054469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
    Xia H; Yu W; Liu M; Li H; Pang W; Wang L; Zhang Y
    Oncol Lett; 2019 Sep; 18(3):2985-2994. PubMed ID: 31452777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.